Passive Immunization of Newborn Rhesus Macaques Prevents Oral Simian Immunodeficiency Virus Infection, The Journal of Infectious Diseases, vol.177, issue.5, pp.1247-1259, 1998. ,
DOI : 10.1086/515270
Neutralizing Antibodies Administered Before, but Not After, Virulent SHIV Prevent Infection in Macaques, AIDS Research and Human Retroviruses, vol.14, issue.12, pp.1035-1043, 1998. ,
DOI : 10.1089/aid.1998.14.1035
Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J Virol, vol.73, pp.4009-4018, 1999. ,
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nat Med, vol.6, pp.200-206, 2000. ,
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, AIDS, vol.15, pp.207-210, 2000. ,
DOI : 10.1097/00002030-200102001-00018
Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques, AIDS, vol.17, issue.3, pp.301-309, 2003. ,
DOI : 10.1097/00002030-200302140-00003
Fc receptor but not complement binding is important in antibody protection against HIV, Nature, vol.75, issue.7158, pp.101-104, 2007. ,
DOI : 10.1038/nature06106
Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques, Nature Medicine, vol.59, issue.8, pp.951-954, 2009. ,
DOI : 10.1038/nm.1974
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers, PLoS Pathogens, vol.81, issue.5, p.1000433, 2009. ,
DOI : 10.1371/journal.ppat.1000433.t004
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody, Proceedings of the National Academy of Sciences, vol.108, issue.27, pp.11181-11186, 2011. ,
DOI : 10.1073/pnas.1103012108
Development of bivalent rgp120 vaccines to prevent HIV type 1 infection, AIDS Res Hum Retroviruses, vol.14, pp.277-289, 1998. ,
Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3, AIDS Res Hum Retroviruses, pp.14-325, 1998. ,
Development of Bivalent (B/E) Vaccines Able to Neutralize CCR5-Dependent Viruses from the United States and Thailand, Virology, vol.265, issue.1, pp.1-9, 1999. ,
DOI : 10.1006/viro.1999.0031
Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV???1 Infection in a Phase 3 HIV???1 Preventive Vaccine Trial, The Journal of Infectious Diseases, vol.191, issue.5, pp.666-677, 2005. ,
DOI : 10.1086/428405
Placebocontrolled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection, J Infect Dis, vol.191, pp.654-665, 2005. ,
Randomized, Double???Blind, Placebo???Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV???1 Vaccine among Injection Drug Users in Bangkok, Thailand, The Journal of Infectious Diseases, vol.194, issue.12, pp.1661-1671, 2006. ,
DOI : 10.1086/508748
Magnitude and Breadth of a Nonprotective Neutralizing Antibody Response in an Efficacy Trial of a Candidate HIV???1 gp120 Vaccine, The Journal of Infectious Diseases, vol.202, issue.4, pp.595-605, 2010. ,
DOI : 10.1086/654816
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand, New England Journal of Medicine, vol.361, issue.23, pp.2209-2220, 2009. ,
DOI : 10.1056/NEJMoa0908492
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus, Nature, vol.372, issue.7446, pp.469-476, 2013. ,
DOI : 10.1038/nature12053
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors, Science, vol.340, issue.6133, pp.711-716, 2013. ,
DOI : 10.1126/science.1234150
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies, The Journal of Experimental Medicine, vol.67, issue.4, pp.655-663, 2013. ,
DOI : 10.1126/science.1192819
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization, Cell, vol.153, issue.1, pp.126-138, 2013. ,
DOI : 10.1016/j.cell.2013.03.018
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding, Science, vol.333, issue.6049, pp.1633-1637, 2011. ,
DOI : 10.1126/science.1207227
Broadly Neutralizing Antiviral Antibodies, Annual Review of Immunology, vol.31, issue.1, pp.705-742, 2013. ,
DOI : 10.1146/annurev-immunol-032712-095916
HIV-1 neutralizing antibodies: understanding nature's pathways, Immunological Reviews, vol.6, issue.1, pp.225-244, 2013. ,
DOI : 10.1111/imr.12075
Children born to women with HIV-1 infection: natural history and risk of transmission, Lancet, vol.337, pp.253-260, 1991. ,
Mother???to???Child Transmission of Human Immunodeficiency Virus Type 1 (HIV???1) and Its Determinants: A Cohort Study in Kigali, Rwanda, American Journal of Epidemiology, vol.137, issue.6, pp.589-599, 1993. ,
DOI : 10.1093/oxfordjournals.aje.a116716
Mother-to-child transmission of HIV-1 in Congo, central Africa, AIDS, vol.8, issue.10, pp.1451-1456, 1994. ,
DOI : 10.1097/00002030-199410000-00012
Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries, JAMA, vol.283, issue.9, pp.1175-1182, 2000. ,
DOI : 10.1001/jama.283.9.1175
Vertical transmission of HIV-2, The Lancet, vol.335, issue.8697, pp.1103-1104, 1990. ,
DOI : 10.1016/0140-6736(90)92682-8
A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau, Aids, vol.7, pp.989-993, 1993. ,
Prospective Comparison of Mother-to-Child Transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast, JAMA: The Journal of the American Medical Association, vol.272, issue.6, pp.462-466, 1994. ,
DOI : 10.1001/jama.1994.03520060062033
Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates ofHIV-1 and HIV-2 in The Gambia, AIDS, vol.14, issue.4, pp.441-448, 2000. ,
DOI : 10.1097/00002030-200003100-00019
Mother???to???Child Transmission of HIV???2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF???CO1, Clinical Infectious Diseases, vol.51, issue.7, pp.833-843, 2010. ,
DOI : 10.1086/656284
Risk factors for mother-to-child transmission of HIV-1, The Lancet, vol.339, issue.8800, pp.1007-1012, 1992. ,
DOI : 10.1016/0140-6736(92)90534-A
Cellular and plasma viral load in patients infected with HIV-2, AIDS, vol.7, issue.11, pp.1411-1417, 1993. ,
DOI : 10.1097/00002030-199311000-00002
Lower Human Immunodeficiency Virus (HIV) Type 2 Viral Load Reflects the Difference in Pathogenicity of HIV???1 and HIV???2, The Journal of Infectious Diseases, vol.180, issue.4, pp.1116-1121, 1999. ,
DOI : 10.1086/315010
Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa, AIDS, vol.14, issue.4, pp.339-344, 2000. ,
DOI : 10.1097/00002030-200003100-00006
Factors associated with clinical progression in HIV-2 infected-patients, AIDS, vol.17, issue.18, pp.2593-2601, 2003. ,
DOI : 10.1097/00002030-200312050-00006
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France, AIDS, vol.22, issue.4, pp.457-468, 2008. ,
DOI : 10.1097/QAD.0b013e3282f4ddfc
URL : https://hal.archives-ouvertes.fr/inserm-00258131
Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy, American Journal of Reproductive Immunology, vol.173, issue.5 ,
DOI : 10.1111/j.1600-0897.1996.tb00172.x
Placental transport of immunoglobulin G, Vaccine, vol.21, issue.24, pp.3365-3369, 2003. ,
DOI : 10.1016/S0264-410X(03)00334-7
Fetal and maternal immunoglobulin levels during pregnancy, American Journal of Obstetrics and Gynecology, vol.103, issue.7, pp.895-900, 1969. ,
DOI : 10.1016/S0002-9378(16)34434-9
Correlations between the concentrations of the four sub-classes of IgG and Gm allotypes in normal human sera, J Immunol, vol.108, pp.195-206, 1972. ,
Placental transfer of immunoglobulin G subclasses, Clin Diagn Lab Immunol, vol.1, pp.667-669, 1994. ,
Human IgG Subclasses in Maternal and Fetal Serum, Vox Sanguinis, vol.7, issue.6, pp.481-492, 1971. ,
DOI : 10.1111/j.1423-0410.1971.tb04808.x
Gamma G subgroups in human fetal, cord, and maternal sera, Clinical Immunology and Immunopathology, vol.2, issue.1, pp.62-66, 1973. ,
DOI : 10.1016/0090-1229(73)90036-6
Maternal-Fetal Transport of Immunoglobulin G and Its Subclasses During the Third Trimester of Human Pregnancy, American Journal of Reproductive Immunology, vol.12, issue.1, pp.8-14, 1994. ,
DOI : 10.1111/j.1600-0897.1994.tb00873.x
THE ELECTROPHORETIC ANALYSIS OF MATERNAL AND FETAL PLASMAS AND SERA, Journal of Clinical Investigation, vol.24, issue.1, pp.46-53, 1945. ,
DOI : 10.1172/JCI101577
Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport, Nature, vol.38, issue.5040, pp.1070-1071, 1966. ,
DOI : 10.1038/2101070a0
Evidence for Efficient Vertical Transfer of Maternal HIV-1 Envelope???Specific Neutralizing Antibodies but No Association of Such Antibodies With Reduced Infant Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.64, issue.2, 2013. ,
DOI : 10.1097/QAI.0b013e31829f6e41
Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis, J Virol, vol.65, pp.6266-6276, 1991. ,
Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts., Proceedings of the National Academy of Sciences, vol.88, issue.24, pp.11236-11240, 1991. ,
DOI : 10.1073/pnas.88.24.11236
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection, J Virol, vol.67, pp.3345-3356, 1993. ,
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission, Science, vol.303, issue.5666, pp.2019-2022, 2004. ,
DOI : 10.1126/science.1093137
HIV???1 Variation before Seroconversion in Men Who Have Sex with Men: Analysis of Acute/Early HIV Infection in the Multicenter AIDS Cohort Study, The Journal of Infectious Diseases, vol.197, issue.7, pp.1011-1015, 2008. ,
DOI : 10.1086/529206
Virus Population Homogenization following Acute Human Immunodeficiency Virus Type 1 Infection, Journal of Virology, vol.76, issue.23, pp.11953-11959, 2002. ,
DOI : 10.1128/JVI.76.23.11953-11959.2002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC136917
Gender differences in HIV-1 diversity at time of infection, Nature Medicine, vol.4, issue.1, pp.71-75, 2000. ,
DOI : 10.1046/j.1537-2995.1995.35295125745.x
Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1, J Virol, vol.69, pp.8118-8122, 1995. ,
HIV-1 genomic rna diversification following sexual and parenteral virus transmission, Virology, vol.189, issue.1, pp.103-110, 1992. ,
DOI : 10.1016/0042-6822(92)90685-I
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants, Science, vol.255, issue.5048, pp.1134-1137, 1992. ,
DOI : 10.1126/science.1546316
Genotypic and phenotypic characterization of HIV-1 patients with primary infection, Science, vol.261, issue.5125, pp.1179-1181, 1993. ,
DOI : 10.1126/science.8356453
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proceedings of the National Academy of Sciences, vol.105, issue.21, pp.7552-7557, 2008. ,
DOI : 10.1073/pnas.0802203105
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men, PLoS Pathogens, vol.5, issue.5, p.1000890, 2010. ,
DOI : 10.1371/journal.ppat.1000890.t003
Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users, Journal of Virology, vol.84, issue.12, pp.6241-6247, 2010. ,
DOI : 10.1128/JVI.00077-10
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 ,
Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1, PLoS Pathogens, vol.13, issue.1, p.1000274, 2009. ,
DOI : 10.1371/journal.ppat.1000274.s004
HIV-1 Sequence Variation Between Isolates from Mother-Infant Transmission Pairs, AIDS Research and Human Retroviruses, vol.8, issue.7, pp.1297-1300, 1992. ,
DOI : 10.1089/aid.1992.8.1297
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers., Proceedings of the National Academy of Sciences, vol.90, issue.5, pp.1721-1725, 1993. ,
DOI : 10.1073/pnas.90.5.1721
Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission, Journal of General Virology, vol.74, issue.9, pp.1747-1756, 1993. ,
DOI : 10.1099/0022-1317-74-9-1747
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission., Journal of Clinical Investigation, vol.94, issue.5, pp.2060-2067, 1994. ,
DOI : 10.1172/JCI117560
Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission., Journal of Clinical Investigation, vol.93, issue.1, pp.380-390, 1994. ,
DOI : 10.1172/JCI116970
Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission, J Virol, vol.69, pp.1001-1012, 1995. ,
Analysis of envelope sequence variants suggests multiple mechanisms of mother-to-child transmission of human immunodeficiency virus type 1, J Virol, vol.69, pp.3778-3788, 1995. ,
Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1, J Virol, vol.72, pp.8493-8501, 1998. ,
V3 Sequence Diversity of HIV-1 Subtype E in Infected Mothers and Their Infants, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.18, issue.4, pp.323-331, 1998. ,
DOI : 10.1097/00042560-199808010-00003
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. JV i r o l2001, pp.2194-2203 ,
Phylogenetic and Phenotypic Analysis of HIV Type 1 Env gp120 in Cases of Subtype C Mother-to-Child Transmission, AIDS Research and Human Retroviruses, vol.18, issue.18, pp.1415-1423, 2002. ,
DOI : 10.1089/088922202320935492
Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A, Journal of Virology, vol.77, issue.5, pp.3050-3057, 2003. ,
DOI : 10.1128/JVI.77.5.3050-3057.2003
Role of Maternal Autologous Neutralizing Antibody in Selective Perinatal Transmission of Human Immunodeficiency Virus Type 1 Escape Variants, Journal of Virology, vol.80, issue.13, pp.6525-6533, 2006. ,
DOI : 10.1128/JVI.02658-05
Neutralization Escape Variants of Human Immunodeficiency Virus Type 1 Are Transmitted from Mother to Infant, Journal of Virology, vol.80, issue.2, pp.835-844, 2006. ,
DOI : 10.1128/JVI.80.2.835-844.2006
Cloning and Characterization of Functional Subtype A HIV-1 Envelope Variants Transmitted Through Breastfeeding, Current HIV Research, vol.5, issue.2, pp.189-197, 2007. ,
DOI : 10.2174/157016207780076986
Genetic variation in mother???child acute seroconverter pairs from Zambia, AIDS, vol.22, issue.7, pp.817-824, 2008. ,
DOI : 10.1097/QAD.0b013e3282f486af
The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother???infant pairs, AIDS, vol.22, issue.7, pp.863-871, 2008. ,
DOI : 10.1097/QAD.0b013e3282f51ea0
Sequences in Mother???Infant Pairs Infected with HIV???1 Subtype CRF01_AE, The Journal of Infectious Diseases, vol.198, issue.6, pp.868-876, 2008. ,
DOI : 10.1086/591251
Correction: Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants, PLoS ONE, vol.5, issue.3, p.9294, 2010. ,
DOI : 10.1371/annotation/c2dd3548-93b7-480e-991a-93a728bca5fe
Genotypic and functional properties of early infant HIV-1 envelopes, Retrovirology, vol.8, issue.1, p.67, 2011. ,
DOI : 10.1128/JVI.02006-06
The Genetic Bottleneck in Vertical Transmission of Subtype C HIV-1 Is Not Driven by Selection of Especially Neutralization-Resistant Virus from the Maternal Viral Population, Journal of Virology, vol.85, issue.16, pp.8253-8262, 2011. ,
DOI : 10.1128/JVI.00197-11
Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants, Retrovirology, vol.10, issue.1, p.3, 2013. ,
DOI : 10.1007/978-1-59745-170-3_26
Sequences Demonstrate Limited Compartmentalization in Breast Milk and Suggest Viral Replication within the Breast That Increases with Mastitis, Journal of Virology, vol.84, issue.20, pp.10812-10819, 2010. ,
DOI : 10.1128/JVI.00543-10
Restriction of HIV-1 Genotypes in Breast Milk Does Not Account for the Population Transmission Genetic Bottleneck That Occurs following Transmission, PLoS ONE, vol.5, issue.4, p.10213, 2010. ,
DOI : 10.1371/journal.pone.0010213.t002
Origin and Evolution of HIV-1 in Breast Milk Determined by Single-Genome Amplification and Sequencing, Journal of Virology, vol.85, issue.6, pp.2751-2763, 2011. ,
DOI : 10.1128/JVI.02316-10
Selection for Human Immunodeficiency Virus Type 1 Envelope Glycosylation Variants with Shorter V1-V2 Loop Sequences Occurs during Transmission of Certain Genetic Subtypes and May Impact Viral RNA Levels, Journal of Virology, vol.79, issue.10, pp.6528-6531, 2005. ,
DOI : 10.1128/JVI.79.10.6528-6531.2005
Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B, Journal of Virology, vol.79, issue.10, pp.6523-6527, 2005. ,
DOI : 10.1128/JVI.79.10.6523-6527.2005
Envelope glycoproteins of Human Immunodeficiency Virus type 1 variants issued from mother???infant pairs display a wide spectrum of biological properties, Virology, vol.426, issue.1, pp.12-21, 2012. ,
DOI : 10.1016/j.virol.2012.01.017
Broad neutralization coverage of HIV by multiple highly potent antibodies, Nature, vol.26, issue.7365, pp.466-470, 2011. ,
DOI : 10.1038/nature10373
Evolution of an HIV glycan???dependent broadly neutralizing antibody epitope through immune escape, Nature Medicine, vol.70, issue.11, pp.1688-1692, 2012. ,
DOI : 10.1128/JVI.00239-07
Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1, AIDS, vol.7, issue.2, pp.45-48, 1993. ,
DOI : 10.1097/00002030-199311002-00010
Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1: Correlation with Neutralizing Antibodies against Primary Isolates, Journal of Infectious Diseases, vol.168, issue.1, pp.207-210, 1993. ,
DOI : 10.1093/infdis/168.1.207
Neutralization Titres and Vertical HIV-1 Transmission, Scandinavian Journal of Immunology, vol.56, issue.6, pp.642-644, 2002. ,
DOI : 10.1046/j.1365-3083.2002.01174.x
Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity, Scandinavian Journal of Immunology, vol.90, issue.3, pp.302-309, 2001. ,
DOI : 10.1046/j.1365-3083.2001.00866.x
Features of HIV-1 That Could Influence Maternal-Child Transmission, JAMA: The Journal of the American Medical Association, vol.272, issue.6, pp.467-474, 1994. ,
DOI : 10.1001/jama.1994.03520060067034
Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmission, Virology, vol.400, issue.2, pp.164-174, 2010. ,
DOI : 10.1016/j.virol.2009.12.019
Lack of Correlation Between Vertical Transmission of HIV-1 and Maternal Antibody Titers Against Autologous Virus in Human Monocyte-Derived Macrophages, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.17, issue.1, pp.92-94, 1998. ,
DOI : 10.1097/00042560-199801010-00015
Neutralizing Antibody and Perinatal Transmission of Human Immunodeficiency Virus Type 1, AIDS Research and Human Retroviruses, vol.14, issue.6, pp.475-481, 1998. ,
DOI : 10.1089/aid.1998.14.475
HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission, PLoS ONE, vol.401, issue.7, p.69274, 2013. ,
DOI : 10.1371/journal.pone.0069274.t002
Revisiting the Role of Neutralizing Antibodies in Mother???to???Child Transmission of HIV???1, The Journal of Infectious Diseases, vol.193, issue.11, pp.1504-1511, 2006. ,
DOI : 10.1086/503778
Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission, Virology, vol.387, issue.2, pp.388-394, 2009. ,
DOI : 10.1016/j.virol.2009.02.024
The Breadth and Titer of Maternal HIV-1-Specific Heterologous Neutralizing Antibodies Are Not Associated with a Lower Rate of Mother-to-Child Transmission of HIV-1, Journal of Virology, vol.86, issue.19, pp.10540-10546, 2012. ,
DOI : 10.1128/JVI.00518-12
The Breadth and Potency of Passively Acquired Human Immunodeficiency Virus Type 1-Specific Neutralizing Antibodies Do Not Correlate with the Risk of Infant Infection, Journal of Virology, vol.85, issue.11, pp.5252-5261, 2011. ,
DOI : 10.1128/JVI.02216-10
Passively Transmitted gp41 Antibodies in Babies Born from HIV-1 Subtype C-Seropositive Women: Correlation between Fine Specificity and Protection, Journal of Virology, vol.86, issue.8, pp.4129-4138, 2012. ,
DOI : 10.1128/JVI.06359-11
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals, PLoS Pathogens, vol.79, issue.8, p.1001028, 2010. ,
DOI : 10.1371/journal.ppat.1001028.s011
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?, Nature Medicine, vol.453, pp.866-870, 2009. ,
DOI : 10.1038/nm.1949
Antibody Specificities Associated with Neutralization Breadth in Plasma from Human Immunodeficiency Virus Type 1 Subtype C-Infected Blood Donors, Journal of Virology, vol.83, issue.17, pp.8925-8937, 2009. ,
DOI : 10.1128/JVI.00758-09
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals, PLoS ONE, vol.5, issue.1, p.8805, 2010. ,
DOI : 10.1371/journal.pone.0008805.s006
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target, Science, vol.326, issue.5950, pp.285-289, 2009. ,
DOI : 10.1126/science.1178746
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1, Science, vol.329, issue.5993, pp.856-861, 2010. ,
DOI : 10.1126/science.1187659
Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses, Science, vol.337, issue.6091, pp.183-186, 2012. ,
DOI : 10.1126/science.1225416
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600854
Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects, AIDS Research and Human Retroviruses, vol.15, issue.15, pp.1365-1376, 1999. ,
DOI : 10.1089/088922299310070
Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-Type 1-Infected Individuals, AIDS Research and Human Retroviruses, vol.20, issue.9, pp.972-988, 2004. ,
DOI : 10.1089/aid.2004.20.972
Transfer of antibody via mother's milk, Vaccine, vol.21, issue.24, pp.3374-3376, 2003. ,
DOI : 10.1016/S0264-410X(03)00336-0
HIV-Specific Functional Antibody Responses in Breast Milk Mirror Those in Plasma and Are Primarily Mediated by IgG Antibodies, Journal of Virology, vol.85, issue.18, pp.9555-9567, 2011. ,
DOI : 10.1128/JVI.05174-11
Limited Contribution of Mucosal IgA to Simian Immunodeficiency Virus (SIV)-Specific Neutralizing Antibody Response and Virus Envelope Evolution in Breast Milk of SIV-Infected, Lactating Rhesus Monkeys, Journal of Virology, vol.84, issue.16, pp.8209-8218, 2010. ,
DOI : 10.1128/JVI.00656-10
Human Immunodeficiency Virus (HIV)???Specific Antibody in Cervicovaginal Lavage Specimens Obtained from Women Infected with HIV Type 1, Clinical Infectious Diseases, vol.35, issue.5, pp.611-617, 2002. ,
DOI : 10.1086/342201
Predominate HIV1-Specific IgG Activity in Various Mucosal Compartments of HIV1-Infected Individuals, Clinical Immunology, vol.97, issue.1, pp.59-68, 2000. ,
DOI : 10.1006/clim.2000.4910
Quantitation of HIV-1-Specific IgG, IgA, and IgM Antibodies in Human Genital Tract Secretions, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.15, issue.3, pp.185-191, 1997. ,
DOI : 10.1097/00042560-199707010-00001
Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding, New Microbiol, vol.23, pp.85-92, 2000. ,
Cervicovaginal Secretory Antibodies to Human Immunodeficiency Virus Type 1 (HIV???1) that Block Viral Transcytosis through Tight Epithelial Barriers in Highly Exposed HIV???1???Seronegative African Women, The Journal of Infectious Diseases, vol.184, issue.11, pp.1412-1422, 2001. ,
DOI : 10.1086/324375
The Antibody Response to SIV in Lactating Rhesus Macaques, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.2, pp.135-141, 2005. ,
DOI : 10.1097/01.qai.0000148947.03416.b5
Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants, The Journal of Pediatrics, vol.149, issue.5, pp.611-616, 2006. ,
DOI : 10.1016/j.jpeds.2006.06.017
Secretory Anti???Human Immunodeficiency Virus (HIV) Antibodies in Colostrum and Breast Milk Are Not a Major Determinant of the Protection of Early Postnatal Transmission of HIV, The Journal of Infectious Diseases, vol.181, issue.2, pp.532-539, 2000. ,
DOI : 10.1086/315255
HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads, PLoS Pathogens, vol.5, issue.6, p.1002739, 2012. ,
DOI : 10.1371/journal.ppat.1002739.s004
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges, Immunity, vol.34, issue.2, pp.269-280, 2011. ,
DOI : 10.1016/j.immuni.2011.01.015
Anti-HIV IgA isotypes, AIDS, vol.27, issue.9, pp.13-20, 2013. ,
DOI : 10.1097/QAD.0b013e328360eac6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084966
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1, JVirol, vol.68, pp.4821-4828, 1994. ,
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody, J Virol, vol.65, pp.6188-6193, 1991. ,
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, J Virol, vol.70, pp.1100-1108, 1996. ,
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J Virol, vol.67, pp.6642-6647, 1993. ,
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41, Journal of Virology, vol.75, issue.22, pp.10892-10905, 2001. ,
DOI : 10.1128/JVI.75.22.10892-10905.2001
Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins, J Acquir Immune Defic Syndr, vol.5, pp.639-646, 1992. ,
Persistent infection of rhesus macaques with T-cell-line-tropic and macrophagetropic clones of simian/human immunodeficiency viruses (SHIV) ,
Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells, J Virol, vol.65, pp.3514-3520, 1991. ,
Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus, Journal of General Virology, vol.73, issue.11, pp.732983-2987, 1992. ,
DOI : 10.1099/0022-1317-73-11-2983
The Construction and Evaluation of SIV/HIV Chimeras That Express the Envelope of European HIV Type 1 Isolates, AIDS Research and Human Retroviruses, vol.13, issue.9, pp.797-800, 1997. ,
DOI : 10.1089/aid.1997.13.797
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high http://www.retrovirology.com/content/10/1/103 in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys, J Virol, vol.70, pp.3198-3206, 1996. ,
Infection and Pathogenicity of Chimeric Simian???Human Immunodeficiency Viruses in Macaques: Determinants of High Virus Loads and CD4 Cell Killing, The Journal of Infectious Diseases, vol.176, issue.2, pp.362-373, 1997. ,
DOI : 10.1086/514053
Evidence for Persistent, Occult Infection in Neonatal Macaques following Perinatal Transmission of Simian-Human Immunodeficiency Virus SF162P3, Journal of Virology, vol.81, issue.2, pp.822-834, 2007. ,
DOI : 10.1128/JVI.01759-06
Postnatal Passive Immunization of Neonatal Macaques with a Triple Combination of Human Monoclonal Antibodies against Oral Simian-Human Immunodeficiency Virus Challenge, Journal of Virology, vol.75, issue.16, pp.7470-7480, 2001. ,
DOI : 10.1128/JVI.75.16.7470-7480.2001
Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge, Journal of Medical Primatology, vol.31, issue.3, pp.109-119, 2002. ,
DOI : 10.1034/j.1600-0684.2002.01014.x
Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian???Human Immunodeficiency Virus by Human Anti???HIV Monoclonal Antibodies, The Journal of Infectious Diseases, vol.189, issue.12, pp.2167-2173, 2004. ,
DOI : 10.1086/420833
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques, Virology, vol.358, issue.1, pp.69-78, 2007. ,
DOI : 10.1016/j.virol.2006.07.056
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody, Nature, vol.183, issue.7424, pp.406-412, 2012. ,
DOI : 10.1038/nature11544
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design, Science, vol.334, issue.6060, pp.1289-1293, 2011. ,
DOI : 10.1126/science.1213782
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo, Proceedings of the National Academy of Sciences, vol.109, issue.46, pp.18921-18925, 2012. ,
DOI : 10.1073/pnas.1214785109
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice, Nature, vol.79, issue.7427, pp.118-122, 2012. ,
DOI : 10.1038/nature11604
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques, Nature Medicine, vol.16, issue.10, pp.1117-1119, 2010. ,
DOI : 10.1038/nm.2233
Antiretroviral Drugs to Prevent Mother-to-Child Transmission of HIV During Breastfeeding, Current HIV Research, vol.11, issue.2, pp.102-125, 2013. ,
DOI : 10.2174/1570162X11311020004
Prevention of Mother-to-Child HIV-1 Transmission???Why We Still Need a Preventive HIV Immunization Strategy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.58, issue.4, pp.359-362, 2011. ,
DOI : 10.1097/QAI.0b013e318235517e
Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV???Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185, The Journal of Infectious Diseases, vol.179, issue.3, pp.567-575, 1999. ,
DOI : 10.1086/314637
Safety and Efficacy of HIV Hyperimmune Globulin for Prevention of Mother-to-Child HIV Transmission in HIV-1???Infected Pregnant Women and Their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.58, issue.4, pp.399-407, 2011. ,
DOI : 10.1097/QAI.0b013e31822f8914
Passive immunization with human neutralizing monoclonal antibodies: correlates of protective immunity against HIV, Vaccine, vol.20, issue.15, pp.1956-1960, 2002. ,
DOI : 10.1016/S0264-410X(02)00077-4
Immunoprophylaxis to Prevent Mother-to-Child Transmission of HIV-1, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.35, issue.2, pp.169-177, 2004. ,
DOI : 10.1097/00126334-200402010-00012
Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B, PLoS Medicine, vol.308, issue.7, p.255, 2006. ,
DOI : 10.1371/journal.pmed.0030255.t003
Short Communication: HIV Type 1 Subtype C Variants Transmitted Through the Bottleneck of Breastfeeding Are Sensitive to New Generation Broadly Neutralizing Antibodies Directed Against Quaternary and CD4-Binding Site Epitopes, AIDS Research and Human Retroviruses, vol.29, issue.3, pp.511-515, 2013. ,
DOI : 10.1089/aid.2012.0197
Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies, AIDS, vol.27, issue.3, pp.337-346, 2013. ,
DOI : 10.1097/QAD.0b013e32835cadd6
HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype, AIDS, vol.27, issue.10, pp.1535-1544, 2013. ,
DOI : 10.1097/QAD.0b013e32835faba5